1. Purdue Pharma to plead guilty to three criminal charges in OxyContin case — Biogen cutting MS and SMA meds from program — Demand for Abbott Labs COVID-19 tests eclipses 100 million as pandemic continues — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice
Latest trending news COVID-19 and your job

How CMOs can help reduce your manufacturing risk

Discussion in 'Pharma Contract Manufacturing - General Discussion' started by anonymous, Mar 8, 2012 at 3:57 PM.

Tags: Add Tags
  1. #1 anonymous, Mar 8, 2012 at 3:57 PM
    anonymous

    anonymous Guest

    This new white paper is hosted at Pharmaceutical Technology. Contract manufacturing organizations (CMOs) exist in an environment of continuous improvement and evolving quality standards.

    http://www.pharmtech.com/pharmtech/...cturing/ArticleStandard/Article/detail/758711

    By scientifically affirming every decision and by embracing integral approaches to quality, CMOs can reduce regulatory risk and become a leader in developing best practices meeting current Good Manufacturing Practices (cGMPs).
     
    Quote

Reply to Thread